NCT04589039View on ClinicalTrials.gov

A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea

CompletedOBSERVATIONAL
Enrollment

662

Participants

Timeline

Start Date

March 16, 2020

Primary Completion Date

September 11, 2024

Study Completion Date

September 11, 2024

Conditions
Ovarian Neoplasms
Trial Locations (1)

48108

Inje University Haeundae Paik Hospital, Busan

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT04589039 - A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea | Biotech Hunter | Biotech Hunter